Related Experiment Video
Updated: Aug 10, 2026
08:18
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
A plasmacytoma-specific factor binds the c-myc promoter region
1Department of Biological Chemistry, University of California, Los Angeles 90024.
Summary
Researchers identified a specific protein in plasmacytomas that binds to the murine c-myc gene promoter. This binding may explain the reduced c-myc gene activity in these cancer cells.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The murine c-myc gene is crucial in cell proliferation and differentiation.
- Dysregulation of c-myc is implicated in various cancers, including plasmacytomas.
- Understanding c-myc gene regulation is key to deciphering cancer development.
Purpose of the Study:
- To investigate proteins binding to the 5' flanking region of the murine c-myc gene.
- To identify proteins involved in regulating c-myc expression during B-cell development and in plasmacytomas.
- To elucidate the role of specific DNA-protein interactions in c-myc transcriptional repression.
Main Methods:
- Electrophoretic mobility-shift assay (EMSA) to detect DNA-protein interactions.
- Comparison of protein binding in B-cell development stages versus plasmacytomas.
- Methylation-interference and o-phenanthroline/copper-protection assays to pinpoint binding sites.
Main Results:
- A plasmacytoma-specific protein was identified that binds to the c-myc promoter region.
- This protein binds to a specific site 290 base pairs upstream of the P1 transcription start site.
- Homologous sequences to the binding site were found at other locations in the murine c-myc locus.
- Five other promoter regions showed sequence-specific binding, but not exclusively in plasmacytomas.
Conclusions:
- The identified plasmacytoma-specific protein likely plays a role in repressing the normal c-myc gene in plasmacytomas.
- This finding offers insights into the molecular mechanisms underlying c-myc dysregulation in cancer.
- Further research can explore therapeutic strategies targeting this protein-DNA interaction.
More Related Videos
Related Concept Videos
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.